Published in Thromb Haemost on June 18, 1980
A myosin I isoform in the nucleus. Science (2000) 2.37
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry (2004) 1.73
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry (1996) 1.53
[Cholesterol--a marker for multiple risk factors? A comparison between coronary disease and coronary health]. Dtsch Med Wochenschr (1992) 1.39
Comparative studies on the inhibition of trypsin, plasmin, and thrombin by derivatives of benzylamine and benzamidine. Eur J Biochem (1968) 1.31
DNA bending by the silencer protein NeP1 is modulated by TR and RXR. Nucleic Acids Res (1996) 1.20
Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield. Respir Med (2012) 1.19
Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes. Biochim Biophys Acta (2000) 1.19
Differential expression and functions of cortical myosin IIA and IIB isotypes during meiotic maturation, fertilization, and mitosis in mouse oocytes and embryos. Mol Biol Cell (1998) 1.16
Functional evidence of distinct ATP activation sites at the human P2X(7) receptor. J Physiol (2001) 1.16
Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am J Physiol (1996) 1.14
Effects of lidocaine on single cardiac sodium channels. J Mol Cell Cardiol (1987) 1.10
Two types of transient outward currents in cardiac ventricular cells of mice. Pflugers Arch (1987) 1.07
Influence of extracellular monovalent cations on pore and gating properties of P2X7 receptor-operated single-channel currents. Biophys J (2007) 1.05
Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches. Biomed Biochim Acta (1985) 1.05
Hirudin and derivatives as anticoagulant agents. Thromb Haemost (1991) 1.02
Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J (2016) 1.01
Block by extracellular Mg2+ of single human purinergic P2X4 receptor channels expressed in human embryonic kidney cells. Neurosci Lett (2000) 1.01
Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant (2007) 1.01
Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry (2002) 1.00
Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol (2001) 0.99
Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med (2012) 0.98
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology (2002) 0.98
Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med (2008) 0.98
Nonselective cationic currents elicited by extracellular ATP in human B-lymphocytes. Pflugers Arch (1995) 0.98
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther (1994) 0.98
Characterisation of postjunctional alpha-adrenoceptors in isolated human femoral veins and arteries. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.98
Kinetics of P2X7 receptor-operated single channels currents. Biophys J (2006) 0.98
The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies). J Neural Transm Gen Sect (1992) 0.97
Influence of room lighting on grey-scale perception with a CRT-and a TFT monitor display. Dentomaxillofac Radiol (2002) 0.96
Autocatalytic peptide bond cleavages in prothrombin and meizothrombin. Biochemistry (1998) 0.96
Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology (2004) 0.95
Pharmacological survey of recombinant hirudin. Pharmazie (1988) 0.95
Ultrasonic force microscopy on strained antimony nanoparticles. Ultramicroscopy (2007) 0.95
Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell (1998) 0.94
Cerebellar haemorrhage and tension pneumocephalus after resection of a Pancoast tumour. Acta Neurochir (Wien) (2005) 0.93
Desynchronising effect of the endothelium on intracellular Ca2+ concentration dynamics in vascular smooth muscle cells of rat mesenteric arteries. Cell Calcium (2002) 0.92
Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2). Pancreas (1998) 0.92
Influence of displayed image size on radiographic detection of approximal caries. Dentomaxillofac Radiol (2003) 0.92
Acute bleeding into a filum terminale ependymoma. Neurosurg Rev (1990) 0.91
Dipetalogastin, a potent thrombin inhibitor from the blood-sucking insect. Dipetalogaster maximus cDNA cloning, expression and characterization. Eur J Biochem (1999) 0.91
Fibroblast contractility without an increase in basal myosin light chain phosphorylation in wild type cells and cells expressing the catalytic domain of myosin light chain kinase. J Biol Chem (1995) 0.91
Clinico-pharmacological studies with recombinant hirudin. Thromb Res (1988) 0.90
Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol (2001) 0.90
Modulation of single cardiac sodium channels by DPI 201-106. Gen Physiol Biophys (1987) 0.90
Smooth muscle myosin II and alpha smooth muscle actin expression in the baboon (Papio anubis) uterus is associated with glandular secretory activity and stromal cell transformation. Biol Reprod (1995) 0.90
[Biochemical and pharmacological aspects of the thrombin inhibitor hirudin]. Pharmazie (1981) 0.90
Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine. J Med Chem (1997) 0.90
Electrophysiological characterization of human keratinocytes using the patch-clamp technique. Exp Dermatol (2000) 0.89
Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am J Ind Med (2007) 0.89
A new system for cutting brain tissue preserving vessels: water jet cutting. Br J Neurosurg (1989) 0.88
Pharmacokinetics of 125I-hirudin in rats and dogs. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.88
Platelet functions in recombinant hirudin-anticoagulated blood. Haemostasis (1990) 0.88
Modified gating behaviour of aconitine treated single sodium channels from adult cardiac myocytes. Pflugers Arch (1986) 0.88
Urea utilization in the phototrophic bacterium Rhodobacter capsulatus is regulated by the transcriptional activator NtrC. J Bacteriol (2001) 0.88
Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin. Pathophysiol Haemost Thromb (2004) 0.88
Silicon based tandem cells: novel photocathodes for hydrogen production. Phys Chem Chem Phys (2014) 0.87
Acetylcholine-induced K+ currents in smooth muscle cells of intact rat small arteries. J Physiol (1997) 0.87
Twenty colloid cysts--comparison of endoscopic and microsurgical management. Minim Invasive Neurosurg (2001) 0.86
Advances in the development of thrombin inhibitors. Expert Opin Investig Drugs (2001) 0.86
Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull (2001) 0.86
Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemost (1982) 0.86
Heparin-induced release of plasminogen activator. Haemostasis (1977) 0.86
Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors. Eur J Pharmacol (2000) 0.86
Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology (2000) 0.85
[Visual evoked potentials in pattern motion]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1983) 0.85
Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin. Thromb Res (1983) 0.85
[Purification and analysis of the thrombin inhibitor hirudin]. Hoppe Seylers Z Physiol Chem (1967) 0.85
Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons. J Pharm Sci (1999) 0.85
Isolation and characterization of a thrombin inhibitor from the tick ixodes ricinus. Pharmazie (1991) 0.85
Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol (2001) 0.85
[p-Aminomethylbenzoic acid (PAMBA), a new antifibrinolytic agent. Experimental animal studies]. Munch Med Wochenschr (1965) 0.84
Assay of hirudin in plasma using a chromogenic thrombin substrate. Thromb Res (1985) 0.84
Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells. Cancer (1997) 0.84
Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria. Toxicol Appl Pharmacol (2001) 0.84
Different toxic effects of ouabain and 16-epi-gitoxin on Purkinje fibres and ventricular muscle fibres. Pharmacology (1976) 0.84
[Studies on the influence of papaverine on reactions of the blood platelets]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.84
Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol (2012) 0.84
HELLP syndrome with haemaglobin vasospasm. J Clin Neurosci (2000) 0.83
Pharmacological approaches to thrombin regulation. Ann N Y Acad Sci (1986) 0.83
Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells. Int J Pancreatol (1998) 0.83
Nephrotoxicant inhibition of renal proximal tubule cell regeneration. Am J Physiol (1995) 0.83
Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb Haemost (1984) 0.83
Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Exp Pathol (Jena) (1980) 0.83
Studies in experimental animals on disseminated intravascular coagulation (DIC). Thromb Diath Haemorrh (1975) 0.83
Alterations in serum and brain trace element levels after antidepressant treatment. Part II. Copper. Biol Trace Elem Res (2000) 0.83
Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Neuropharmacology (2007) 0.83
Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants. Semin Thromb Hemost (1992) 0.83
Effects of growth hormone administration in pediatric renal allograft recipients. Pediatr Nephrol (1992) 0.82
A novel PAR-1-type thrombin receptor signaling pathway: cyclic AMP-independent activation of PKA in SNB-19 glioblastoma cells. Biochem Biophys Res Commun (2001) 0.82
Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells. Br J Pharmacol (1999) 0.82
Drug-dependent ion channel gating by application of concentration jumps using U-tube technique. Methods Enzymol (1999) 0.82